StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Kiora Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.51M. For fiscal 2025 it was -$9.96M, down 216.4% from the year before. The highest annual figure on record is $8.56M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.96M-216.4%
FY2024Dec 31, 2024$8.56M–
FY2023Dec 31, 2023-$9.56M–
FY2022Dec 31, 2022-$10.43M–
FY2021Dec 31, 2021-$10.68M–
FY2020Dec 31, 2020-$7.32M–
FY2019Dec 31, 2019-$8.15M–
FY2018Dec 31, 2018-$10.84M–
FY2017Dec 31, 2017-$6.47M–
FY2016Dec 31, 2016-$8.41M–
FY2015Dec 31, 2015-$4.46M–
FY2014Dec 31, 2014-$950.62K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.89M–
Q1 FY2026Mar 31, 2026-$3.16M–
Q4 FY2025Dec 31, 2025-$2.18M–
Q3 FY2025Sep 30, 2025-$1.27M-238.4%
Q2 FY2025Jun 30, 2025-$3.80M–
Q1 FY2025Mar 31, 2025-$2.70M-119.8%
Q4 FY2024Dec 31, 2024-$2.25M–
Q3 FY2024Sep 30, 2024$920.06K–
Q2 FY2024Jun 30, 2024-$3.73M–
Q1 FY2024Mar 31, 2024$13.62M–
Q4 FY2023Dec 31, 2023-$2.58M–
Q3 FY2023Sep 30, 2023-$2.52M–
Q2 FY2023Jun 30, 2023-$1.38M–
Q1 FY2023Mar 31, 2023-$3.07M–
Q4 FY2022Dec 31, 2022-$2.13M–
Q3 FY2022Sep 30, 2022-$2.97M–
Q2 FY2022Jun 30, 2022-$2.50M–
Q1 FY2022Mar 31, 2022-$2.83M–
Q4 FY2021Dec 31, 2021-$2.92M–
Q3 FY2021Sep 30, 2021-$2.27M–
Q2 FY2021Jun 30, 2021-$2.92M–
Q1 FY2021Mar 31, 2021-$2.57M–
Q4 FY2020Dec 31, 2020-$1.71M–
Q3 FY2020Sep 30, 2020-$1.74M–
Q2 FY2020Jun 30, 2020-$1.47M–
Q1 FY2020Mar 31, 2020-$2.40M–
Q4 FY2019Dec 31, 2019-$2.59M–
Q3 FY2019Sep 30, 2019-$2.00M–
Q2 FY2019Jun 30, 2019-$1.42M–
Q1 FY2019Mar 31, 2019-$2.15M–
Q4 FY2018Dec 31, 2018-$2.00M–
Q3 FY2018Sep 30, 2018-$2.78M–
Q2 FY2018Jun 30, 2018-$1.95M–
Q1 FY2018Mar 31, 2018-$4.11M–
Q4 FY2017Dec 31, 2017-$1.45M–
Q3 FY2017Sep 30, 2017-$2.52M–
Q2 FY2017Jun 30, 2017-$2.48M–
Q1 FY2017Mar 31, 2017-$18.60K–
Q4 FY2016Dec 31, 2016-$2.05M–
Q3 FY2016Sep 30, 2016-$2.33M–

More Kiora Pharmaceuticals figures

See a number that looks wrong?